JP2023512454A5 - - Google Patents
Info
- Publication number
- JP2023512454A5 JP2023512454A5 JP2022542670A JP2022542670A JP2023512454A5 JP 2023512454 A5 JP2023512454 A5 JP 2023512454A5 JP 2022542670 A JP2022542670 A JP 2022542670A JP 2022542670 A JP2022542670 A JP 2022542670A JP 2023512454 A5 JP2023512454 A5 JP 2023512454A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- binding domain
- terminus
- amino terminus
- carboxyl terminus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025184163A JP2026021465A (ja) | 2020-01-13 | 2025-10-31 | タンパク質治療のための製剤 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062960562P | 2020-01-13 | 2020-01-13 | |
| US62/960,562 | 2020-01-13 | ||
| US202063121633P | 2020-12-04 | 2020-12-04 | |
| US63/121,633 | 2020-12-04 | ||
| PCT/US2021/013294 WO2021146328A1 (en) | 2020-01-13 | 2021-01-13 | Formulations for protein therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025184163A Division JP2026021465A (ja) | 2020-01-13 | 2025-10-31 | タンパク質治療のための製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023512454A JP2023512454A (ja) | 2023-03-27 |
| JP2023512454A5 true JP2023512454A5 (https=) | 2024-01-22 |
Family
ID=74592744
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022542670A Pending JP2023512454A (ja) | 2020-01-13 | 2021-01-13 | タンパク質治療のための製剤 |
| JP2025184163A Pending JP2026021465A (ja) | 2020-01-13 | 2025-10-31 | タンパク質治療のための製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025184163A Pending JP2026021465A (ja) | 2020-01-13 | 2025-10-31 | タンパク質治療のための製剤 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230303720A1 (https=) |
| EP (1) | EP4090367A1 (https=) |
| JP (2) | JP2023512454A (https=) |
| KR (1) | KR20220127843A (https=) |
| CN (1) | CN115279406A (https=) |
| AU (1) | AU2021207470A1 (https=) |
| BR (1) | BR112022013725A2 (https=) |
| CA (1) | CA3164385A1 (https=) |
| IL (1) | IL294458A (https=) |
| MX (1) | MX2022008654A (https=) |
| WO (1) | WO2021146328A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109952112B (zh) | 2016-09-21 | 2024-09-06 | 阿帕特夫研究和发展有限公司 | Cd123结合蛋白和相关的组合物和方法 |
| DK4364724T3 (da) | 2018-05-10 | 2025-12-22 | Regeneron Pharma | Formuleringer med høj koncentration af VEGF-receptorfusionsprotein |
| WO2020232247A1 (en) | 2019-05-14 | 2020-11-19 | Provention Bio, Inc. | Methods and compositions for preventing type 1 diabetes |
| IL298999A (en) | 2020-06-11 | 2023-02-01 | Provention Bio Inc | Methods and compositions for the prevention of type 1 diabetes |
| JP2024520444A (ja) | 2021-05-24 | 2024-05-24 | プロヴェンション・バイオ・インコーポレイテッド | １型糖尿病を治療するための方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283173A (en) | 1990-01-24 | 1994-02-01 | The Research Foundation Of State University Of New York | System to detect protein-protein interactions |
| GB9518220D0 (en) | 1995-09-06 | 1995-11-08 | Medical Res Council | Checkpoint gene |
| US6440418B1 (en) | 1995-11-07 | 2002-08-27 | Idec Pharmaceuticals Corporation | Methods of treating autoimmune diseases with gp39-specific antibodies |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| JP2008501621A (ja) | 2003-05-31 | 2008-01-24 | マイクロメット アクツィエン ゲゼルシャフト | Ｂ細胞関連疾患を処置するための二重特異性抗ｃｄ３、抗ｃｄ１９抗体構築物を含む薬学的組成物 |
| DK1629011T3 (da) | 2003-05-31 | 2010-05-03 | Micromet Ag | Humane anti-humane-DC3-bindingsmolekyler |
| MXPA06004035A (es) | 2003-10-16 | 2006-08-31 | Micromet Ag | Aglutinantes cd3 de-inmunizados multi-especificos. |
| US7393662B2 (en) | 2004-09-03 | 2008-07-01 | Centocor, Inc. | Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| NZ573646A (en) | 2006-06-12 | 2012-04-27 | Wyeth Llc | Single-chain multivalent binding proteins with effector function |
| TW200831129A (en) * | 2006-10-06 | 2008-08-01 | Amgen Inc | Stable formulations |
| MX2009010611A (es) | 2007-04-03 | 2010-03-26 | Micromet Ag | Enlazadores biespecificos, especificos para especies. |
| JP2011526792A (ja) | 2008-07-02 | 2011-10-20 | エマージェント プロダクト デベロップメント シアトル， エルエルシー | ＴＮＦ−αアンタゴニスト多重標的結合性タンパク質 |
| US20110293619A1 (en) | 2008-10-01 | 2011-12-01 | Micromet Ag | CROSS-SPECIES-SPECIFIC PSMAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
| NO2344540T3 (https=) | 2008-10-02 | 2018-04-28 | ||
| US20130129723A1 (en) | 2009-12-29 | 2013-05-23 | Emergent Product Development Seattle, Llc | Heterodimer Binding Proteins and Uses Thereof |
| CA2785907A1 (en) | 2009-12-29 | 2011-07-28 | Emergent Product Development Seattle, Llc | Ron binding constructs and methods of use thereof |
| TWI653333B (zh) | 2010-04-01 | 2019-03-11 | 安進研究（慕尼黑）有限責任公司 | 跨物種專一性之ＰＳＭＡｘＣＤ３雙專一性單鏈抗體 |
| AU2011286024B2 (en) | 2010-08-02 | 2014-08-07 | Macrogenics, Inc. | Covalent diabodies and uses thereof |
| KR102060389B1 (ko) | 2011-05-21 | 2019-12-31 | 마크로제닉스, 인크. | 사람 및 비-사람 cd3에 결합할 수 있는 cd3-결합 분자 |
| JP6509724B2 (ja) | 2012-04-20 | 2019-05-08 | アプティーボ リサーチ アンド デベロップメント エルエルシー | Ｃｄ３結合ポリペプチド |
| WO2016094873A2 (en) | 2014-12-12 | 2016-06-16 | Emergent Product Development Seattle, Llc | Receptor tyrosine kinase-like orphan receptor 1 binding proteins and related compositions and methods |
| CN114181309B (zh) | 2015-05-21 | 2024-07-30 | 鳄鱼生物科学公司 | 新型多肽 |
| WO2017053469A2 (en) * | 2015-09-21 | 2017-03-30 | Aptevo Research And Development Llc | Cd3 binding polypeptides |
| CN109952112B (zh) * | 2016-09-21 | 2024-09-06 | 阿帕特夫研究和发展有限公司 | Cd123结合蛋白和相关的组合物和方法 |
| WO2019050521A1 (en) * | 2017-09-07 | 2019-03-14 | Macrogenics, Inc. | DOSAGE SCHEMES OF BISPECIFIC DIACORPS CD123 X CD3 IN THE TREATMENT OF HEMATOLOGICAL MALIGNANCIES |
-
2021
- 2021-01-13 WO PCT/US2021/013294 patent/WO2021146328A1/en not_active Ceased
- 2021-01-13 JP JP2022542670A patent/JP2023512454A/ja active Pending
- 2021-01-13 BR BR112022013725A patent/BR112022013725A2/pt unknown
- 2021-01-13 MX MX2022008654A patent/MX2022008654A/es unknown
- 2021-01-13 KR KR1020227026642A patent/KR20220127843A/ko active Pending
- 2021-01-13 US US17/802,920 patent/US20230303720A1/en active Pending
- 2021-01-13 EP EP21704990.7A patent/EP4090367A1/en active Pending
- 2021-01-13 CN CN202180020514.1A patent/CN115279406A/zh active Pending
- 2021-01-13 IL IL294458A patent/IL294458A/en unknown
- 2021-01-13 AU AU2021207470A patent/AU2021207470A1/en active Pending
- 2021-01-13 CA CA3164385A patent/CA3164385A1/en active Pending
-
2025
- 2025-10-31 JP JP2025184163A patent/JP2026021465A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023512454A5 (https=) | ||
| JP2025090743A5 (https=) | ||
| Mould et al. | Identification of a novel recognition sequence for the integrin alpha 4 beta 1 in the COOH‐terminal heparin‐binding domain of fibronectin. | |
| JP2021503485A5 (https=) | ||
| JP2020501532A5 (https=) | ||
| JP2019531093A5 (https=) | ||
| HRP20130194T1 (hr) | Imunosupresivni polipeptidi i nukleinske kiseline | |
| JP2020517260A5 (https=) | ||
| RU2018100181A (ru) | Модифицированный белок интерлейкина-7 и способы его применения | |
| JP2018510622A5 (https=) | ||
| ES8606390A1 (es) | Un procedimiento para preparar nuevos peptidos atriales. | |
| JP2017113019A5 (https=) | ||
| JP2017522002A5 (https=) | ||
| AR119902A1 (es) | Proteínas de fusión terapéuticas | |
| CN110088120A (zh) | 转谷氨酰胺酶的抑制剂 | |
| JP2020504143A5 (https=) | ||
| WO2016115511A3 (en) | Vegf variant polypeptide compositions | |
| JP2024508969A5 (https=) | ||
| FI3720875T3 (fi) | Antimikrobiset peptidit ja menetelmät niiden käyttöön | |
| JP2013529178A5 (https=) | ||
| JPWO2021070696A5 (https=) | ||
| WO2018081448A8 (en) | Modified immunoglobulin hinge regions to reduce hemagglutination | |
| JP2025512749A5 (https=) | ||
| JP2022539560A5 (https=) | ||
| JP2005509160A5 (https=) |